Xpeng (XPEV) had the highest return in 2022 and on November 30, 2022 by a mid-cap US stock, returning 26.6%.
| ASSET | % RETURN |
|---|---|
Xpeng (XPEV) | 26.58% |
Terawulf (WULF) | 16.9% |
Regencell Bioscience (RGC) | 15.8% |
Immunome (IMNM) | 15.33% |
GDS (GDS) | 15.22% |
Full Truck Alliance Co Ltd ADR (YMM) | 14.96% |
Youdao (DAO) | 14.35% |
Grindr (GRND) | 13.69% |
Kingsoft Cloud Holdings (KC) | 13.53% |
Nio Inc Class A ADR (NIO) | 12.7% |
Navitas Semiconductor (NVTS) | 11.21% |
NeoGenomics (NEO) | 11.1% |
Figs (FIGS) | 11.06% |
Arcus Biosciences (RCUS) | 10.91% |
Adaptive Biotechnologies (ADPT) | 10.58% |
Zai Lab (ZLAB) | 10.55% |
Compass (COMP) | 10.33% |
10X Genomics (TXG) | 10.27% |
Archer Aviation (ACHR) | 10.09% |
Pulse Biosciences (PLSE) | 9.89% |
Monday (MNDY) | 9.52% |
Lifestance Health (LFST) | 9.46% |
Peloton Interactive (PTON) | 9.19% |
Atour Lifestyle Holdings Limited American Depositary Shares (ATAT) | 8.94% |
Vertex (VERX) | 8.87% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.